IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of cash flow

(in CHF 1 000)

 

 

Notes

 

01.01.–31.03.2021

 

01.01.–31.03.2020

Cash flows from operating activities

 

 

 

 

 

 

Proceeds from sales of securities

 

4

 

199 408

 

162 314

Purchase of securities

 

4

 

(284 562)

 

(168 120)

Dividend receipts

 

 

 

 

243

Payments for services

 

 

 

(14 870)

 

(12 274)

Income taxes paid

 

 

 

 

(45)

Total cash flows from operating activities

 

 

 

(100 024)

 

(17 882)

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

Dividend

 

 

 

(199 440)

 

(188 360)

Proceeds from sales of treasury shares

 

6

 

9 398

 

Borrowing of bank loans

 

5

 

287 000

 

187 000

Interest payments

 

 

 

(43)

 

(225)

Total cash flows from financing activities

 

 

 

96 915

 

(1 585)

 

 

 

 

 

 

 

Foreign exchange difference

 

 

 

207

 

38

Change in cash and cash equivalents

 

 

 

(2 902)

 

(19 429)

 

 

 

 

 

 

 

Cash and cash equivalents at the beginning of the period

 

 

 

6 816

 

30 707

 

 

 

 

 

 

 

Cash and cash equivalents at the end of the period

 

 

 

3 914

 

11 278

The notes are an integral part of the condensed consolidated interim financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience.Use of cookies & disclaimer